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Introduction
• DLBCL has poor survival with current 1st and 2nd line 
therapies
• Anti-CD19 CAR T cells (tisagenlecleucel) have a ~50% 
complete response rate in r/r cases 
– BUT costs ~$475,000
• Objective: correlate response to CAR T cell to the 
bulkiness of tumor burden
Introduction
• Previous research showed increased risk of adverse 
effects (i.e. tumor lysis) with increased tumor burden 
• Currently no data predicting response based on 
baseline imaging





– Does average index lesion area correlate to 
response outcome in r/r DLBCL treated with CAR T 
cells?
• Hypothesis
– Higher average index lesion area correlates to 
increased incidence of progressive disease 
following r/r DLBCL treated with CAR T cells. 
Approach & Results
• Secondary data analysis
• Population: 20 r/r DLBCL pts treated with anti-CD19 
chimeric antigen receptor T cells
• No intervention (data analysis)
• Comparison: low vs high tumor bulk
• Outcome: Response to tisagenlecleucel
• Data source and collection: index lesions on baseline CT 
scan per Chesson criteria, response outcomes
Approach & Results
• Analysis 
– ROC AUC, Chi square (a=0.05)
• Findings
– ROC AUC = 68%
• Aggregate measure of metric performance
– Cutoff value of 7 cm2
• Sensitivity = 100%, FPR = 50%
• Next lowest FPR was 33% with sensitivity of 62.5% at 
4cm2 cutoff.
– Chi square = 5.71 (p=0.017)

Conclusions
• Low tumor bulk (<7cm2) showed statistically 
significant correlation with higher response rate to 
tisagenlecleucel
– Need further data to increase confidence in result
• Demonstrates potential for clinical utility in 
treatment decisions for r/r DLBCL
Future Directions
• Repeat analysis with larger sample size using 
non-clinical trial patients
• Assess other factors that could predict 
outcome (cytokine levels, peak CAR T cell 
levels)
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